Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Jullien

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
Clinical Pharmacokinetics|April 24, 2009
Population pharmacokinetics and dosing recommendations for cisplatin during intraperitoneal peroperative administration: development of a limited sampling strategy for toxicity risk assessmentBernard Royer, Vincent Jullien, Emmanuel Guardiola, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
Iatrogenic Cushing's syndrome induced by posaconazoleBenoit Pilmis, Hélène Coignard-Biehler, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|June 2, 2025
Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to <i>Stenotrophomonas maltophilia</i>Jonathan Wong-So, Sophie Magréault, Étienne Carbonnelle, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 21, 2007
Quantification of darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detectionLauriane Goldwirt, Stéphanie Chhun, Elisabeth Rey, et al.
British Journal of Clinical Pharmacology|April 11, 2012
Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitisNaïm Bouazza, Vincent Pestre, Vincent Jullien, et al.
Therapeutic Drug Monitoring|July 2, 2024
From Bed to Bench: Pre-analytical Stability of 29 Anti-infective Agents in Plasma and Whole Blood to Improve Accuracy of Therapeutic Drug MonitoringSophie Magreault, Dorine Pierredon, Judith Akinotcho-Relouzat, et al.
Pharmacotherapy|December 1, 2010
Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosisEmmanuelle Guillot, Isabelle Sermet, Agnès Ferroni, et al.
Journal of Clinical Pharmacology|July 21, 2015
Pilot evaluation of the population pharmacokinetics of bumetanide in term newborn infants with seizuresVincent Jullien, Ronit M Pressler, Geraldine Boylan, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Evaluation of cefotaxime and desacetylcefotaxime concentrations in cord blood after intrapartum prophylaxis with cefotaximeJacques Lepercq, Jean Marc Treluyer, Christelle Auger, et al.
Investigative Radiology|August 10, 2016
Adverse Reactions to Gadoterate Meglumine: Review of Over 25 Years of Clinical Use and More Than 50 Million DosesEric de Kerviler, Kenneth Maravilla, Jean-François Meder, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Clinical Pharmacokinetics|April 24, 2009
Population pharmacokinetics and dosing recommendations for cisplatin during intraperitoneal peroperative administration: development of a limited sampling strategy for toxicity risk assessmentBernard Royer, Vincent Jullien, Emmanuel Guardiola, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
Iatrogenic Cushing's syndrome induced by posaconazoleBenoit Pilmis, Hélène Coignard-Biehler, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|June 2, 2025
Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to <i>Stenotrophomonas maltophilia</i>Jonathan Wong-So, Sophie Magréault, Étienne Carbonnelle, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 21, 2007
Quantification of darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detectionLauriane Goldwirt, Stéphanie Chhun, Elisabeth Rey, et al.
British Journal of Clinical Pharmacology|April 11, 2012
Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitisNaïm Bouazza, Vincent Pestre, Vincent Jullien, et al.
Therapeutic Drug Monitoring|July 2, 2024
From Bed to Bench: Pre-analytical Stability of 29 Anti-infective Agents in Plasma and Whole Blood to Improve Accuracy of Therapeutic Drug MonitoringSophie Magreault, Dorine Pierredon, Judith Akinotcho-Relouzat, et al.
Pharmacotherapy|December 1, 2010
Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosisEmmanuelle Guillot, Isabelle Sermet, Agnès Ferroni, et al.
Journal of Clinical Pharmacology|July 21, 2015
Pilot evaluation of the population pharmacokinetics of bumetanide in term newborn infants with seizuresVincent Jullien, Ronit M Pressler, Geraldine Boylan, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Evaluation of cefotaxime and desacetylcefotaxime concentrations in cord blood after intrapartum prophylaxis with cefotaximeJacques Lepercq, Jean Marc Treluyer, Christelle Auger, et al.
Investigative Radiology|August 10, 2016
Adverse Reactions to Gadoterate Meglumine: Review of Over 25 Years of Clinical Use and More Than 50 Million DosesEric de Kerviler, Kenneth Maravilla, Jean-François Meder, et al.
Pageof 13